J01DC02 • cefuroxime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Second-generation cephalosporins
Cefuroxime is a second-generation cephalosporin antibiotic used to treat moderate bacterial infections. It is indicated for upper respiratory tract infections (such as sinusitis, tonsillitis, or pharyngitis), lower respiratory tract infections (bronchitis, pneumonia), urinary tract infections, otitis media, skin and soft tissue infections, as well as some bone and joint infections.
Cefuroxime works by inhibiting bacterial cell wall synthesis, killing the bacteria responsible for the infection. It is available in tablet, oral suspension, or injectable solution form.
Side effects may include nausea, diarrhea, abdominal pain, skin rashes, or allergic reactions. In rare cases, it can cause pseudomembranous colitis or severe hypersensitivity reactions. It is contraindicated in patients with allergies to cephalosporins or penicillins.
Substance: cefuroxime
Date of last drug list: 01-03-2024
Commercial code: W64617008
Concentration: 250mg
Pharmaceutical form: tablets
Quantity: 50
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: MEDOCHEMIE LTD. (FACTORY C) - CIPRU
Holder: MEDOCHEMIE LTD. - CIPRU
Number: 10659/2018/08
Shelf life: 3 years
powder for intramuscular / intravenous injection solution
powder for intravenous injection solution
powder for intravenous / infusible solution for injection
powder for injection / infusion solution
powder for intravenous / intramuscular injection solution / suspension
suspension powder (intramuscular) / injection solution (intramuscular / intravenous)
powder for intramuscular injection suspension / intravenous injection solution
powder for injection suspension or intramuscular / intravenous injection solution